You are viewing: North America Plasma Fractionation Market analysis
Part of: Plasma Fractionation Market (Global)

The North America Plasma Fractionation Market was valued at $19715.6 Million in 2026 and projected to reach to $28658.5 Million by 2031, representing a compound annual growth rate of 7.8%. North America's plasma fractionation market is poised for significant expansion through 2031, supported by increasing diagnosis rates of immunodeficiency disorders, aging population demographics, and enhanced patient awareness.

North America Plasma Fractionation Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America Plasma Fractionation Market Trends and Insights

  • The region is experiencing robust growth driven by advanced healthcare infrastructure, high demand for immunoglobulin therapies, and increasing prevalence of immunodeficiency disorders.
  • North America's market is expected to expand significantly, reaching USD 28,658.5 million by 2031, reflecting a compound annual growth rate of 7.8%. The North America plasma fractionation market benefits from strong regulatory frameworks, established plasma collection networks, and substantial investment in biopharmaceutical innovation.
  • North America's aging population and rising incidence of chronic diseases are key factors propelling demand for plasma-derived therapies.
  • The region's market growth is further supported by technological advancements in fractionation processes and expanding applications across hemophilia, immunodeficiency, and thrombotic disorders. North America maintains its leadership position through continuous product development and strategic partnerships among major plasma fractionation manufacturers.
  • The market's trajectory from 2026 to 2031 underscores North America's commitment to advancing plasma therapeutics and meeting evolving patient needs across diverse clinical indications..

Key Market Statistics

  • CAGR (2026-2031) 7.8% CAGR
  • Market Size, 2026 ~USD 19715.6 Million
  • Forecast, 2031 ~USD 28658.5 Million
  • Geography North America

North America Plasma Fractionation Market Overview

Market Dominance :

North America commands the largest share of the global plasma fractionation market, with the US alone representing USD 26,537.8 million in 2026, driven by sophisticated healthcare infrastructure and high treatment adoption rates.

Immunoglobulin Therapy Demand :

Rising prevalence of primary immunodeficiency disorders and secondary immunodeficiency conditions across North America is fueling robust demand for immunoglobulin therapies, the largest product segment in the region.

Advanced Healthcare Ecosystem :

North America's well-established regulatory framework, reimbursement policies, and presence of leading plasma collection centers support sustained market expansion and innovation in fractionation technologies.

Strong Growth Trajectory :

The region is projected to grow from USD 19,715.6 million in 2026 to USD 28,658.5 million by 2031, representing a 7.8% CAGR, outpacing global average growth and reflecting increasing clinical adoption.

North America Plasma Fractionation Market Dynamics

  • The region benefits from robust healthcare spending, advanced clinical infrastructure, and strong regulatory support that facilitate rapid adoption of new plasma-derived therapies.
  • Key drivers include rising demand for albumin, immunoglobulins, and clotting factors across hospital and home-care settings. Market growth will be further accelerated by technological advancements in plasma collection and fractionation processes, expanding reimbursement coverage, and strategic investments by major biopharmaceutical companies.
  • North America's competitive landscape, characterized by established players and emerging innovators, continues to drive product development and market penetration.
  • The region's commitment to plasma self-sufficiency and regulatory excellence positions it as a cornerstone of global plasma fractionation supply..

Market Ecosystem

logo-mobile

PLASMA FRACTIONATION MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Implemented the Horizon 2 plasma fractionation process at its Kankakee facility to improve immunoglobulin recovery from donated plasma Higher immunoglobulin yield | Improved plasma utilization | Greater production efficiency | Increased supply capacity
company logo
Implemented process improvements through its One Day Batch Release program at plasma-derived therapy manufacturing sites to accelerate batch release Faster batch release | Improved manufacturing efficiency | Shorter lead times | Faster product availability

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Pharmaceuticals

    Top Technologies
    • Bioreactors
    • Analytical Testing
    • Bioanalytical Testing Services
    • Cell Counters
    • Data Management Services
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • SANOFI
    • Pfizer Inc.
    • NOVARTIS

      Key Takeaways

      • North America's plasma fractionation market is valued at USD 19,715.6 million in 2026 and is projected to reach USD 28,658.5 million by 2031.
      • North America demonstrates a 7.8% CAGR, driven by advanced healthcare infrastructure and high demand for immunoglobulin therapies.
      • North America's aging population and rising chronic disease prevalence are primary growth catalysts for plasma-derived therapeutics.
      • North America's strong regulatory environment and established plasma collection networks support sustained market expansion through 2031.

      Plasma Fractionation Market Report Scope

      Report Metric Details
      Base Year 2026
      Fastest Growing Segment SCIG (Type)
      Forecast Period 2026-2030
      Growth Rate CAGR of 7.6% from 2026 to 2030
      Largest Segment THERAPEUTICS (Application)
      Market Size Base Year (Billions) ~USD 36.46 (2026)
      Revenue Forecast (Billions) ~USD 48.87 (2030)
      Segments Covered Product, Type, Application, Therapeutic Area, End User

      North America Plasma Fractionation Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Product

      • Albumin
      • Coagulation Factor Concentrates
      • Immunoglobulins
      • Other Plasma Products
      • Protease Inhibitors

      By Type

      • Factor Ix
      • Factor Viii
      • Factor Xiii
      • Fibrinogen Concentrates
      • Ivig
      • Other Coagulation
      • Other Coagulation Factor Concentrates
      • Other Immunoglobulins
      • Prothrombin Complex Concentrates
      • Prothrombin Factor Concentrates
      • Scig
      • Von Willebrand Factor

      By Application

      • Academics & Preclinical Research
      • Therapeutics

      By Therapeutic Area

      • Critical Care
      • Hemato-Oncology
      • Hematology
      • Immunology
      • Neurology
      • Other Therapeutic Areas
      • Pulmonology
      • Rheumatology

      By End User

      • Home Care Settings & Infusion Centers
      • Hospitals & Specialty Clinics
      • Other End Users

      Target Audience

      • Biopharmaceutical Companies : Manufacturers and distributors of plasma-derived therapies need North America market intelligence to guide product launches, pricing strategies, and market expansion within the region's competitive landscape.
      • Healthcare Investors : Private equity firms, venture capitalists, and institutional investors require detailed North America market data to evaluate investment opportunities in plasma fractionation companies and related healthcare assets.
      • Hospital & Clinical Networks : Healthcare providers and hospital systems need market insights to optimize procurement strategies, forecast therapy demand, and plan budget allocations for plasma-derived medicines in North America.
      • Regulatory & Policy Bodies : Government agencies and health authorities in North America utilize market research to inform policy decisions, plasma supply planning, and healthcare resource allocation strategies.
      • Plasma Collection Organizations : Blood banks and plasma donation centers require market forecasts to plan collection capacity, staffing, and infrastructure investments aligned with North America's growing demand for plasma fractionation.

      North America vs. other regions

      HowNorth America compares to the other 3 regional blocs covered in this market.

      Europe
      ~USD 11986.7 Million · 7.3% wtd CAGR ·
      Asia Pacific
      ~USD 8714.7 Million · 8.4% wtd CAGR ·
      Latin America
      ~USD 2826.1 Million · 6.8% wtd CAGR ·
      Middle East
      ~USD 988.6 Million · 4.4% wtd CAGR ·

      Countries within North America - compare and drill down

      Country2025 size (native)
      USUSD 26537.8 Million
      CanadaUSD 2120.7 Million

      Country market size visualization

      US
      USD 26537.8 Million
      Canada
      USD 2120.7 Million

      Reasons to Buy this Report

      • Regional Market Sizing : Obtain precise market valuations for North America (USD 19.7B in 2026) and country-level breakdowns for US and Canada, enabling accurate budget allocation and competitive positioning strategies.
      • Growth Forecasting : Access detailed 5-year projections showing North America's expansion to USD 28.7B by 2031 at 7.8% CAGR, supporting long-term strategic planning and investment decisions.
      • Regulatory & Reimbursement Insights : Understand North America's unique healthcare policies, FDA approval pathways, and insurance coverage dynamics that directly impact market access and commercial success in the region.
      • Competitive Landscape Analysis : Identify leading plasma fractionation companies operating in North America, their market share, product portfolios, and strategic initiatives to benchmark performance and identify partnership opportunities.
      • Clinical Demand Drivers : Analyze prevalence trends of immunodeficiency disorders, aging demographics, and clinical adoption patterns specific to North America to identify high-growth therapeutic segments and patient populations.

      Frequently asked questions

      What is the current size of North America's plasma fractionation market?

      North America's plasma fractionation market is valued at USD 19,715.6 million in 2026 and represents a significant portion of global plasma therapeutics demand.

      What is the projected market size for North America by 2031?

      North America's plasma fractionation market is forecast to reach USD 28,658.5 million by 2031, reflecting sustained growth in plasma-derived therapies.

      What is the CAGR for North America's plasma fractionation market?

      North America's plasma fractionation market is growing at a compound annual growth rate of 7.8% from 2026 to 2031.

      What factors are driving growth in North America's plasma fractionation market?

      North America's market growth is driven by advanced healthcare infrastructure, aging population demographics, rising immunodeficiency disorders, and technological innovations in plasma fractionation.

      Why is North America a key region for plasma fractionation?

      North America leads in plasma fractionation due to strong regulatory frameworks, established plasma collection networks, significant biopharmaceutical investment, and high healthcare spending on specialized therapies.

      RESEARCH METHODOLOGY

      This research study extensively used secondary sources, directories, and databases to identify and collect valuable information for analyzing the global plasma fractionation market. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess the market's growth prospects. The global market size estimated through secondary research was triangulated with inputs from primary research to determine the final market size..

      Secondary Research

      The secondary sources for this research study include publications from government sources, such as FDA/CBER, EMA, WHO, and national health and regulatory authorities; industry associations, such as the Plasma Protein Therapeutics Association (PPTA), the International Plasma and Fractionation Association (IPFA), and AABB; and commercial databases, such as Bloomberg Business, D&B, Factiva, and relevant trade databases. Additional sources include white papers, annual reports, company house documents, investor presentations, scientific and clinical publications, regulatory filings, patent databases, and product and clinical trial databases. Secondary research was used to identify and collect information for the extensive, technical, market-oriented, and commercial study of the plasma fractionation market. It was also used to obtain important information about key players, market classification, segmentation according to industry trends, the bottom-up approach, and key developments from market and technology perspectives. Secondary data was also used to assess plasma collection capacity, fractionation and manufacturing infrastructure, product portfolios, regulatory frameworks, trade patterns, clinical applications, and regional market trends. These sources were also used to gather key information about major players, market classification, and segmentation based on industry trends, regional/country-level markets, market developments, and technological perspectives.

      Primary Research

      In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess the market’s prospects. Primary sources from both the supply and demand sides of the market were interviewed to gather qualitative and quantitative information.

      Plasma Fractionation Market
 Size, and Share

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The top-down and bottom-up approaches were used to estimate & validate the total size of the plasma fractionation market. These methods were also used extensively to estimate the size of various market segments.

      Plasma Fractionation Market : Top-Down and Bottom-Up Approach

      Plasma Fractionation Market Top Down and Bottom Up Approach

      Data Triangulation

      After evaluating the overall market size through the market size estimation process, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were used, whenever applicable, to complete the overall market engineering process and obtain precise statistics for all segments and subsegments. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.

      Market Definition

      Plasma-derived therapies are medical treatments based on human plasma. Plasma is the largest component of human blood and contains water, salts, enzymes, antibodies, and other proteins. Before it can be used in medical therapies, it undergoes a fractionation process in which the relevant proteins are separated. Plasma-derived therapies are used to treat a wide range of (rare) diseases, from bleeding disorders and inhibitor deficiencies to primary and secondary immunodeficiencies.

      Key Stakeholders

      • Plasma Fractionation Product Manufacturers and Distributors
      • Pharmaceutical and Biotechnology Companies
      • Healthcare Service Providers (including Hospitals and Clinics)
      • Research and Development (R&D) companies
      • Academic Institutes
      • Government Associations
      • Market Research and Consulting Firms
      • Venture Capitalists and Investors

      Report Objectives

      • To define, describe, and forecast the plasma fractionation market based on product, application, therapeutic area, end user, and region
      • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
      • To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the overall plasma fractionation market
      • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments concerning six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
      • To strategically profile the key players in the plasma fractionation market and comprehensively analyze their core competencies and market rankings
      • To track and analyze competitive developments such as product launches, acquisitions, expansions, agreements, partnerships, and collaborations in the plasma fractionation market
      • To benchmark players within the plasma fractionation market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and product/service strategy

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:

      Product Analysis

      • Further breakdown of the Rest of Europe Plasma Fractionation Market, by country
      • Further breakdown of the Rest of Asia Pacific Plasma Fractionation Market, by country
      • Further breakdown of the Rest of Latin America Plasma Fractionation Market, by country
      • Further breakdown of the Rest of Middle East Plasma Fractionation Market, by country

      Company Information

      • Detailed analysis and profiling of additional market players (up to five)

      Get the Full Plasma Fractionation Market Report

      Full forecast, segment splits, and company analysis for all Plasma Fractionation Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status